Dissertation · 2025 · Open access

Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells

Laura Ermellino

IRIS · Published 27 August 2025

Open full textCite this paper

In brief

“Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells” is a 2025 dissertation by Laura Ermellino, published in IRIS. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at IRIS.

Citations
0
Authors
1

Abstract

Background. A successful strategy to cure HIV would require eradicating its reservoir, particularly those cells harbouring replication competent HIV particles during antiretroviral therapy (ART), that are mainly represented by lymph node (LN) PD-1+ T follicular helper cells. Hypothesis. In this study, we hypothesized that chimeric antigen receptor (CAR) T cells re-directed against PD-1 could provide an effective tool for targeting and eliminating these cells. We investigated the impact of this approach on the viral rebound in a humanized mouse model of HIV-1 infection. Results part one. We designed two novel second-generation CARs incorporating the single chain variable fragment (scFv) of a blocking (bPD1-CAR) or a nonblocking (nbPD1- CAR) anti-PD-1 monoclonal antibody, fused to an IgG4 hinge, CD28 transmembrane and CD3ζ-4-1BB signalling domains. Anti-PD-1 CAR-T cells were successfully engineered to be HIV resistant by selectively editing the CD4 receptor on the CAR-T cells. The avidity modulated CAR T-cell sensitivity, trogocytosis and effector functions. Remarkably, anti- PD-1 CAR-T cells were able to persist for 70 days in the spleen of humanized mice, disrupting the lymphoid architecture. CAR-T cell expansion in vivo correlated with delayed or absent viral rebound after ART interruption, with the bPD1-CAR showing enhanced viral control. Results part two. To monitor viral load following adoptive cell transfer in in vivo studies, we developed a novel, highly specific triplex qPCR assay capable of quantifying both HIV RNA and CAR RNA avoiding the potential cross-reactivities. Conclusions. This study demonstrates the feasibility to engineer CARs against receptors naturally expressed on T cells. The CAR functional avidity and the level of expression of the target receptor modulated the survival and exhaustion of CAR-T cells. Finally, depletion of PD-1+ cells correlated with the persistence of anti-PD-1 CAR-T cells and HIV viral control upon ART interruption in humanized mice.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ermellino, L. (2025). Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells. IRIS. https://iris.unil.ch/handle/iris/276046

MLA 9

Ermellino, Laura. “Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells.” IRIS, 2025. https://iris.unil.ch/handle/iris/276046.

Chicago

Ermellino, Laura. 2025. “Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells.” IRIS. https://iris.unil.ch/handle/iris/276046.

Harvard

Ermellino, L. (2025) ‘Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells’, IRIS. Available at: https://iris.unil.ch/handle/iris/276046.

IEEE

L. Ermellino, “Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells,” IRIS, 2025.

BibTeX

@phdthesis{ermellino2025tackling,
  title     = {{Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells}},
  author    = {Ermellino, Laura},
  year      = {2025},
  url       = {https://iris.unil.ch/handle/iris/276046}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • HIV reservoir
  • HIV cure
  • viral rebound
  • humanized mice
  • CAR T cell persistence
  • CAR-T cell exhaustion
  • trogocytosis
  • HIV RNA quantification

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Ermellino, L. (2025). Tackling the HIV reservoir with engineered anti-PD-1 CAR-T cells. IRIS. https://iris.unil.ch/handle/iris/276046

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at IRIS: sign in and open the full text from this page.

Who wrote this paper?

Laura Ermellino.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.